Cardioprotection with halogenated gases: how does it occur?
Jose Luis Guerrero-Orriach,1–3 Juan Jose Escalona Belmonte,1 Alicia Ramirez Fernandez,1 Marta Ramirez Aliaga,1 Manuel Rubio Navarro,1 Jose Cruz Mañas1 1Department of Cardioanesthesiology, Virgen de la Victoria University Hospital, 2Instituto de Investigación Biom&...
Main Authors: | Guerrero-Orriach JL, Escalona Belmonte JJ, Ramirez Fernandez A, Ramirez Aliaga M, Rubio Navarro M, Cruz Mañas J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-03-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/cardioprotection-with-halogenated-gases-how-does-it-occur-peer-reviewed-article-DDDT |
Similar Items
-
Beneficial Effects of Halogenated Anesthetics in Cardiomyocytes: The Role of Mitochondria
by: José Luis Guerrero-Orriach, et al.
Published: (2023-09-01) -
Heart Failure after Cardiac Surgery: The Role of Halogenated Agents, Myocardial Conditioning and Oxidative Stress
by: José Luis Guerrero-Orriach, et al.
Published: (2022-01-01) -
Cardioprotective Properties of Mannitol—Involvement of Mitochondrial Potassium Channels
by: Katharina Feige, et al.
Published: (2021-02-01) -
Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning
by: Miki Takayuki, et al.
Published: (2012-06-01) -
Cardioprotective effect of remote ischemic preconditioning with postconditioning on donor hearts in patients undergoing heart transplantation: a single-center, double-blind, randomized controlled trial
by: Guyan Wang, et al.
Published: (2019-04-01)